Related Experiment Video
Updated: Mar 17, 2026

09:17
Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness
Published on: May 2, 2017
9.5K
[POLYNEUROPATHY IN CRITICALLY ILL CHILDREN WITH INFECTIOUS DISEASES]
Anesteziologiia I Reanimatologiia
|July 30, 2016
Summary
Critical illness can cause polyneuropathy in children, affecting 10 out of 14 patients. Severe cases occurred in 40%, primarily impacting lower limb nerves after mechanical ventilation.
Area of Science:
- Pediatric critical care medicine
- Neurology
- Infectious diseases
Background:
- Critically ill children often develop complications affecting multiple organ systems.
- Polyneuropathy in critical illness (CIP) is a known complication in adult intensive care units.
- Data on the incidence and characteristics of CIP in pediatric populations is limited.
Purpose of the Study:
- To assess the incidence and characteristics of polyneuropathy in pediatric patients with critical illnesses.
- To identify risk factors and clinical manifestations of critical illness polyneuropathy in children.
Main Methods:
- Electroneuromyography (ENMG) was performed on 14 critically ill pediatric patients.
- Patients had diverse infectious pathologies.
- Clinical data and neurological assessments were collected.
Main Results:
- Polyneuropathy was diagnosed in 10 out of 14 pediatric patients (71.4%).
- Severe forms of polyneuropathy were observed in 40% of affected children.
- Peripheral nerves of the lower extremities were predominantly affected.
- Polyneuropathy typically developed between the 5th and 7th day of mechanical ventilation.
Conclusions:
- Critical illness polyneuropathy is a common complication in pediatric intensive care.
- Early neurological assessment using ENMG is crucial for diagnosis in critically ill children.
- Understanding the timing and affected nerves can guide management and improve outcomes.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
354
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
354
Pneumonia III: Complications and Assessment
1.1K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism
312
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312
Pharmacokinetics in Pediatric Patients: Drug Distribution
419
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
419

